IDEAYA Biosciences is following closely behind with its combination of darovasertib and crizotinib, a protein kinase C (PKC) inhibitor and cellular mesenchymal-epithelial transcription factor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback